RevOpsis Therapeutics secured $16.5 million in seed funding to develop and commercialize treatments for neovascular AMD
Amount Raised
$16.5 Million
Round Type
Seed
SpringfieldBiotechnologyInvestors
Description
RevOpsis Therapeutics has successfully closed its first seed funding round, raising $16.5 million. The funding will propel its mission to develop and commercialize treatments for chronic multifactorial diseases through the company's proprietary Rev-Mod Platform.
Quick answer
RevOpsis Therapeutics raised $16.5 Million in a Seed round, dated April 25, 2024. Investors: Several Leading Retina Specialists, Ophthalmic Drug And Device Development Firm and Leading Contract Development And Manufacturing Organization (Cdmo). RevOpsis Therapeutics is based in Springfield, Illinois, United States.
- How much did RevOpsis Therapeutics raise?
- RevOpsis Therapeutics raised $16.5 Million in a Seed round on April 25, 2024.
- Who invested in RevOpsis Therapeutics?
- Several Leading Retina Specialists, Ophthalmic Drug And Device Development Firm and Leading Contract Development And Manufacturing Organization (Cdmo) are named as investors in this round.
- What does RevOpsis Therapeutics do?
- RevOpsis Therapeutics is a next-generation biopharmaceutical company that is trailblazing a new era in multispecific antibody discovery and development to unlock transformative treatments for complex disease.
- Where is RevOpsis Therapeutics based and how big is it?
- RevOpsis Therapeutics is based in Springfield, Illinois, United States. Fundz records about 4 employees.
- Who are the decision-makers at RevOpsis Therapeutics?
- Fundz holds 2 contacts at RevOpsis Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as RevOpsis Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Alida Biosciences Inc. raised $7.5M on June 7, 2024.
- Genvax Technologies raised $3.4M on June 7, 2024.
- EvodiaBio raised $7.6M on June 7, 2024.
- DIH Holding US raised $3.3M (Seed) on June 7, 2024.
- GPN Vaccines raised $18M (Series B) on June 7, 2024.
- Oleander Medical Technologies raised $500K on June 7, 2024.
Who to call at RevOpsis Therapeutics, and when
A new round usually means RevOpsis Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day RevOpsis Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RevOpsis Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RevOpsis Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RevOpsis Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
RevOpsis Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.